Recor Medical
Tracked across 1 events · 7 articles · First seen May 15, 2026 · Last active May 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Recor Medical, a subsidiary of Cara, marked World Hypertension Day 2026 by highlighting its Paradise uRDN system, an ultrasound-based renal denervation therapy for uncontrolled high blood pressure. This minimally invasive device aims to reduce overactive…
Impact: Recor Medical developed the Paradise uRDN system, a device-based therapy for hypertension, and is actively working to expand its access globally. This event highlights their innovation and commitment to addressing uncontrolled hypertension.
May 15, 2026 · 7 articles
95
Recor Medical developed systemRecor Medical Highlights...
90
Recor Medical highlights innovationRecor Medical Highlights...
85
United States — Food and Drug Administration approved system Recor MedicalRecor Medical Highlights...
70
Recor Medical received regulatory approval JapanRecor Medical Highlights...
60
Recor Medical advancing evidence generationRecor Medical Highlights...
NEWSDESK
Track Recor Medical live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard